medical – Earlybirds Invest https://earlybirdsinvest.com Latest Crypto News Tue, 09 Sep 2025 20:35:30 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.8 https://i0.wp.com/earlybirdsinvest.com/wp-content/uploads/2024/12/cropped-New-Project-2024-12-17T235703.455.png?fit=32%2C32&ssl=1 medical – Earlybirds Invest https://earlybirdsinvest.com 32 32 240146708 Solana Price Prediction: Medical Firm Bets $1.65B on SOL – Can Solana 10x From Here? https://earlybirdsinvest.com/solana-price-prediction-medical-firm-bets-1-65b-on-sol-can-solana-10x-from-here/ https://earlybirdsinvest.com/solana-price-prediction-medical-firm-bets-1-65b-on-sol-can-solana-10x-from-here/#respond Tue, 09 Sep 2025 20:35:30 +0000 https://earlybirdsinvest.com/solana-price-prediction-medical-firm-bets-1-65b-on-sol-can-solana-10x-from-here/

Content Writer

Harvey Hunter

Content Writer

Harvey Hunter

About Author

Harvey Hunter is a Content Writer at Cryptonews.com. With a background in Computer Science, IT, and Mathematics, he seamlessly transitioned from tech geek to crypto journalist.

Last updated: 

Forward Industries (FORD) is one of many companies making the pivot toward a SOL treasury strategy, fuelling a growing number of bullish Solana price predictions.

The medical manufacturing company is set to become the largest Solana public treasury, with $1.65 billion in funding from Galaxy Digital, Jump Crypto, and Multicoin Capital to accumulate the altcoin.

The biggest public Solana treasury companies. Source: TheBlock.

The current leader, Upexi Inc. (UPXI), holds just over $1 billion in SOL.

Forward Industries aims to generate differentiated onchain returns and build long-term shareholder value through active participation in the Solana ecosystem.

As spot ETFs wait for SEC approval, FORD could serve as a bridge for traditional markets seeking exposure to SOL.

The move underscores a broader corporate shift, with non-financial firms increasingly adding crypto to their public treasuries, positioning SOL for deeper adoption as digital assets enter mainstream balance sheets.

Something which could accelerate in the coming weeks with the U.S. CLARITY Act, which stands to unlock sidelined capital from institutions waiting on regulatory clarity.

Solana Price Prediction: Can Solana 10x on Institutional Demand?

Solana teeters on the edge of a breakout as a confluence zone pushes SOL closer to escaping a rising wedge pattern that has held since the mid-April market bottom.

SOL / USD 1-day chart, confluence zone pushes rising wedge to breakout. Source: TradingView.

A support trendline forming throughout August now retests the upper boundary of the pattern in a potential breakout setup.

This comes as momentum indicators flip decidedly bullish. The RSI has found a stronger footing above the neutral line, reaching 60, confirming strong buy pressure driving the move.

The MACD has also formed a golden cross, surpassing the signal line after hovering indecisively above and below the signal line over the past week.

If this one lasts, it could confirm the start of a longer-term uptrend. With it, a breakout could propel Solana to retest its early-year all-time high near $300.

With this level reclaimed as support, the door opens for new price discovery with little historical support to limit upside, setting sights on the patterns projected $400 target for an 85% gain.

As the bull market matures, momentum could carry further. Greater TradFi demand from potential Solana ETF approval in October could push the Solana price to $1,000, marking a 380% gain.

However, a 10x gain from here to $2,100 is a more likely long-term target with continued institutional adoption.

The Biggest Solana Opportunities Lie in Its Ecosystem – Here’s How to Find Them

With up to 75 bsp of U.S. interest rate cuts expected before year-end, the altcoin market is in for an even stronger run as capital rotates into riskier plays.

Sure, the Solana price could climb 4x. But the true breakout gains are coming from the low-cap meme coins in its ecosystem, delivering 10x–1000x returns.

That’s where Snorter ($SNORT) steps in.

Its purpose-built trading bot is designed to detect momentum early, giving investors the chance to position before a coin goes mainstream, where the real gains start.

Snorter Bot is built for competitive trading: limit-order sniping to grab the sharpest entries, MEV-resistant swaps that shield you from frontrunners, copy trading that mirrors proven winners, and rug-pull protection that helps filter out scams before you commit.

But spotting the entry isn’t a free pass to life-changing gains. Knowing the right time to cash out is what separates good trades from great ones — and Snorter helps you get it right.

Snorter Bot vs. other popular trading bots.

The project is off to a strong start; $SNORT has already raised over $3.8 million in its ongoing presale, likely driven by its high 129% APY on staking to rewards early investors.

To invest:

  • Visit the official Snorter Bot website
  • Connect your wallet (Best Wallet is fully supported)
  • You can swap crypto or even use a bank card to complete the transaction in seconds.

Don’t miss your early entry.

You can keep up with Snorter on X (formerly Twitter) and Instagram.

Visit the Official Website Here


]]>
https://earlybirdsinvest.com/solana-price-prediction-medical-firm-bets-1-65b-on-sol-can-solana-10x-from-here/feed/ 0 57609
Covid vaccines: Trump administration trying to undo the medical miracle https://earlybirdsinvest.com/covid-vaccines-trump-administration-trying-to-undo-the-medical-miracle/ https://earlybirdsinvest.com/covid-vaccines-trump-administration-trying-to-undo-the-medical-miracle/#respond Sun, 31 Aug 2025 15:31:34 +0000 https://earlybirdsinvest.com/covid-vaccines-trump-administration-trying-to-undo-the-medical-miracle/

In his first term, President Donald Trump touted the “medical miracle” of the mRNA Covid-19 vaccine that he helped deliver to market through the unprecedented public-private partnership known as Operation Warp Speed.

In its second term, the Trump administration is dismantling the signature health achievement of his first term by sowing doubt about the safety and efficacy of the Covid-19 vaccine. The president is taking steps to make the vaccine more difficult for the public to receive and for pharmaceutical companies to bring new mRNA vaccines to market.

Secretary of Health and Human Services Robert F. Kennedy Jr. has been a critic and skeptic of vaccines for years, linking them to autism and other disorders without scientific evidence.

Now, Kennedy is canceling grants to develop more mRNA vaccines, which are also being explored for treating the flu, HIV, and cancer.

He fired all 17 members of the Centers for Disease Control and Prevention’s Covid-19 immunization workgroup, the Advisory Committee on Immunization Practices (ACIP), and replaced them with vaccine skeptics. He removed Covid-19 vaccines from the list of shots recommended for healthy pregnant women and children, which means insurance companies will likely no longer pay for them. The Daily Beast reports that the Trump administration is planning to pull the vaccine from shelves “within months,” citing a close associate of Kennedy’s.

Today, Explained co-host Sean Ramewaram spoke with Katherine Wu, staff writer for The Atlantic, about what this means for Americans’ ability to get vaccinated against Covid-19.

Below is an excerpt of their conversation, edited for length and clarity. There’s much more in the full podcast, so listen to Today, Explained wherever you get podcasts, including Apple Podcasts, Pandora, and Spotify.

What is the secretary of health and human services, Robert F. Kennedy Jr., doing right now with mRNA vaccines?

Probably the latest and biggest news is that he canceled half a billion dollars’ worth of grants to develop more mRNA vaccines. The public is probably most familiar with mRNA vaccines in the context of Covid vaccines. That’s the first place we had successful mRNA vaccines, and that is still where mRNA vaccines dominate the market, but they’ve been in development for tons of other diseases, not just infectious ones, for a very long time. So this is a pretty huge deal.

Remind me who was president when the Covid mRNA vaccine was developed?

Also Trump, just during his first term, not this one.

Oh, weird. How has President Trump advanced his campaign to inoculate and protect Americans with mRNA vaccines in his second term so far?

He hasn’t. During the first term, Trump was the one who helped push forward Operation Warp Speed, that big partnership between government and pharma that got us all of these amazing Covid vaccines in record time, and helped us beat back this pandemic that killed so many people. And so far, this shining beacon from Trump’s first term is being systematically ripped apart. We’ve already talked about how Trump’s administration has pulled funding for development of more mRNA vaccines. You would think that we want to build on that success. Not so much. But they’ve also started to strip away Americans’ access to Covid vaccines. They have removed or altered recommendations to get Covid vaccines in certain groups. They’ve made it harder for vaccine makers to get new Covid vaccines to market, and a lot of the new hires and advisors to the Department of Health and Human Services are taking aim at other Covid vaccine recommendations that could restrict access even further. I think it’s very realistic that within a year or two, very few people will be able to get Covid vaccines, even when they want and need them.

We were all there when the Covid vaccines came out, and the president, I believe, was among the first to get them. They were touted as a miracle of medical science. How is that narrative being rewritten right now?

Yeah, it’s fascinating, right? Trump himself used that phrase, medical miracle. And there’s no scientific reason that he should have stopped believing that. The data on these vaccines has not changed. They’re very safe, very effective. They went through all the normal channels of vetting that get us safe, effective vaccines. But right now in his second term, Trump is leading an administration that is mostly pushing out information that these vaccines are dubious. They don’t work. And largely, this whole system is corrupt. All the people that recommended these vaccines have conflicts of interest and they’re in the pocket of industry, and basically the government is working to restrict access to these vaccines so they don’t hurt as many Americans as they could. He said they don’t work against respiratory viruses, which is not true.

Studies have shown that they saved millions of lives during the pandemic, and they continue to protect people for everyone who was receiving them. He said that they were the deadliest vaccine ever made. There’s no evidence to support that. They have done quite the opposite. And he’s cast doubt on the idea that they were studied thoroughly and carefully vetted by expert scientists who knew exactly what safety signals to look for. None of that is backed up by the evidence, but it’s basically what the federal government is saying right now.

These vaccines were famously brought to market very quickly. I mean, that was part of the miracle we’re referring to here that seemed to spur a lot of these conspiracy theories about their efficacy. Was there any validity to the argument that they were produced too quickly, that there wasn’t enough testing?

I think the way you phrase your question is important, right? Because “too quickly” is about, did they arrive so quickly that there wasn’t adequate time to study them, make sure that they worked well to protect against Covid and they did so in a way that wasn’t posing undue risk to the people who receive them? And I think the answer is very soundly no. It’s important to acknowledge that all this was done on the shoulders of all the vaccine science that came before it. Scientists knew what to look for. They knew how to run these trials. They knew how to scale up their technology. And yeah, they did it in ways that were unprecedented, but not unprecedented in ways that they were shooting in the dark.

So what happens now? You were saying that you can see a future in which even people who want and need these vaccines won’t be able to get them. How far away is that?

I think there are still enough people at federal health agencies that would fight back against that, that it could be a very dragged-out fight. Stripping access to those vaccines instantaneously would also probably come under legal challenge quickly, but I think it’s something that a lot of sectors of the administration are starting to move toward.

Operation Warp Speed obviously played a huge role in developing these vaccines, but it wasn’t just an American effort by any means. If the US is falling off right now and denying the medical miracle that was, what’s the rest of the world doing? And does that mean that you could fly to Canada to get your Covid vaccine, or even get it delivered?

Man, black market international vaccines. What a world. Yeah, it’s a great question, and I think there’s a couple things to touch on here. One is that cutting off funding for mRNA vaccine development here cuts off resources for the rest of the world. The US is extremely powerful in terms of scientific firepower, money, and also, up until very recently, foreign aid. If we stop developing vaccines here, that means there are fewer resources for other countries. There’s also a chilling effect that is very likely to happen if the US says: These vaccines are crap, they’re not worth investing in, they’re not worth recommending, they’re not good enough for our people. Other countries have traditionally taken cues from the US, especially around vaccines. Other countries might look at what we’re doing and pause and be like, well, we don’t want to look weird. We don’t want to be the outliers when the US is doing this.

But are we the outliers right now? It feels like we’re the outliers.

We totally are, and I would hope that other countries look at us and then look at the UK, and be like, Okay, maybe we start following the UK. But it’s tricky, because in a landscape where these vaccines get more scarce and more expensive because the US isn’t pouring resources into developing them, those vaccines simply won’t exist or might be worse than if the US were pouring those resources in. And the US is simultaneously saying “These aren’t good enough.” It becomes an economical and almost political decision for other countries to pause a little bit more.

President Trump has taken to wearing a hat that says “Trump was right about everything.” This is a man who loves a win, and he got a huge one in 2020 with the mRNA vaccine for Covid-19. Why do you think he won’t take the win?

I suspect some of this goes back to what happened at the end of his term and what happened in the ensuing presidential term. The end of Trump’s first term was marred by the start of the pandemic. He was widely criticized for letting things get as bad as they did in the US in those early days. Even though he helped push vaccines along, that was a triumph that didn’t completely overshadow all of the other policy hiccups that made 2020 and much of 2021 horrific in this country. The pandemic could have gone much better here if there had been a much better coordinated public health response and better communication. I think a lot of Trump’s base felt angered by that, and they felt angered by a lot of early pandemic policies. They felt betrayed by the government, and I think that has soured Trump’s base on all things Covid, including vaccines.

]]>
https://earlybirdsinvest.com/covid-vaccines-trump-administration-trying-to-undo-the-medical-miracle/feed/ 0 56069
RFK Jr demonstrates exciting new medical technique: wild guessing https://earlybirdsinvest.com/rfk-jr-demonstrates-exciting-new-medical-technique-wild-guessing/ https://earlybirdsinvest.com/rfk-jr-demonstrates-exciting-new-medical-technique-wild-guessing/#respond Thu, 28 Aug 2025 17:36:50 +0000 https://earlybirdsinvest.com/rfk-jr-demonstrates-exciting-new-medical-technique-wild-guessing/

America’s top health official has discovered a revolutionary diagnostic technique called “looking at kids in airports.”

As reported in The Independent, Health Secretary Robert F. Kennedy Jr. — whose medical credentials include having “about 70 of cousins” – announced he can spot “mitochondrial challenges” or “inflammation” in passing children.

“I’m looking at kids while I walk through the airports today, as I walk down the street, and I see these kids that are just overburdened with mitochondrial challenges, inflammation, you can tell it from their faces, from their body movement, and from their lack of social connection,” he told Texas Governor Greg Abbott yesterday.

During the Texas press conference, Kennedy demonstrated his supernatural ability to misread both medical statistics and basic reality. He claimed 38% of teenagers have diabetes or pre-diabetes, which is only off by 37.65%.

His qualifications for this medical clairvoyance? Growing up in a big family where apparently nobody had diabetes, food allergies, or autism. Of course, he was zonked on heroin for a decade-and-a-half, which may have dulled his powers of observation a bit.

The terrifying part isn’t that our nation’s top health official thinks he’s Doctor Strange minus the medical degree – it’s that he’s using this supernatural diagnostic method to shape actual public policy.

Watch out, med schools – your entire curriculum just got replaced by “staring intensely at children in airports.”

]]>
https://earlybirdsinvest.com/rfk-jr-demonstrates-exciting-new-medical-technique-wild-guessing/feed/ 0 55585
Solana Boost – Medical Firm’s $400M Stock Sale Powers New SOL Treasury https://earlybirdsinvest.com/solana-boost-medical-firms-400m-stock-sale-powers-new-sol-treasury/ https://earlybirdsinvest.com/solana-boost-medical-firms-400m-stock-sale-powers-new-sol-treasury/#respond Tue, 26 Aug 2025 04:38:44 +0000 https://earlybirdsinvest.com/solana-boost-medical-firms-400m-stock-sale-powers-new-sol-treasury/

The trend of companies establishing crypto treasuries is gaining momentum, with Sharps Technology—a small player in the medical device and pharmaceutical sector—being the last to announce a plan to raise $400 million through a stock sale aimed at funding Solana (SOL) treasury.

New Solana Treasury In The Makings

The capital raise, which is set to close on August 28, will effectively transform Sharps’ stock into a proxy for the Solana price, attracting backing from crypto investment firms such as ParaFi, Pantera Capital, and CoinFund. 

This infusion of over $400 million positions Sharps to potentially become the largest holder of Solana among publicly traded companies, surpassing its nearest competitor, Upexi, which holds approximately $394 million in the cryptocurrency.

Related Reading

To further strengthen its position in the crypto ecosystem, Sharps has appointed Alice Zhang, a venture capitalist and co-founder of the crypto smartphone maker Jambo, to its board as the new chief investment officer. James Zhang, another co-founder from Jambo, will serve as a strategic advisor. 

Alice Zhang expressed confidence in the new team’s capabilities, stating, “We will have a team with deep ties to the Solana ecosystem and proven founder-level experience in scaling institutional digital asset platforms.”

However, Sharps’ frontrunner status in the Solana treasury market may be short-lived. Fortune reports that major crypto players, including Galaxy Digital, Multicoin Capital, and Jump Crypto, are in the process of raising $1 billion to launch their own Solana treasury company. 

Strategy Expands Bitcoin Holdings

This investment into Sharps is part of a larger trend where small public companies are actively establishing digital asset treasuries, which are essentially pools of cryptocurrency held on their balance sheets. 

This trend extends to the market’s largest altcoins, including XRP, Binance Coin (BNB), and The Open Network’s (TON) native token. This strategy has taken even higher relevance under the US’s leadership in creating a supportive framework for digital assets in the country.

Related Reading

In tandem with these developments, Strategy (previously MicroStrategy), the world’s largest corporate holder of Bitcoin (BTC), announced on Monday that it had acquired additional tokens, taking advantage of the current retrace. 

Between August 18 and August 24, the Bitcoin proxy firm disclosed it purchased 3,081 Bitcoin for approximately $356.9 million, averaging around $115,829 per token.

Michael Saylor, the driving force behind Strategy’s crypto investments, revealed that the firm has achieved a Bitcoin yield of 25.4% year-to-date as of August 24, 2025. With 632,457 Bitcoins acquired for roughly $46.50 billion.

Solana
The daily chart shows SOL’s drop below $200. Source: SOLUSDT on TradingView.com

As of this writing, Solana lost the $200 level in line with the broader market correction that led the cryptocurrency to retrace nearly 5% in the 24-hour time frame. It now trades at $196, meaning a 32% gap from its $293 record high. 

Featured image from DALL-E, chart from TradingView.com 

]]>
https://earlybirdsinvest.com/solana-boost-medical-firms-400m-stock-sale-powers-new-sol-treasury/feed/ 0 55155
Hong Kong’s IVD Medical adds $19 million in ether to its finances https://earlybirdsinvest.com/hong-kongs-ivd-medical-adds-19-million-in-ether-to-its-finances/ https://earlybirdsinvest.com/hong-kongs-ivd-medical-adds-19-million-in-ether-to-its-finances/#respond Fri, 08 Aug 2025 11:50:58 +0000 https://earlybirdsinvest.com/hong-kongs-ivd-medical-adds-19-million-in-ether-to-its-finances/

Another Hong Kong company is adding cryptography to the Ministry of Finance, but wants to do more than passively retain it.

IVD Medical Holdings purchased $19 million ($149 million) The ether (eth)place assets at the heart of real-world asset tokenization strategies.

The company is building IVD.xyz, a platform for tokenizing pharmaceutical intellectual property and other medical assets.

In a statement to Coindesk, Chief Strategy Officer Gary Deng said that Ethereum was chosen as a core asset as it is the “world’s most mature smart contract platform” with “very high liquidity” and growing institutional awareness.

IVD will use ETH to verify chain ownership of tokenized assets, to automatically generate revenue and compliance governance.

It also serves as the payment layer for the company’s planned IVDD Stablecoin, which allows cross-border transactions within Hong Kong and within the US compliance framework. Revenues from RWA transactions are automatically converted to ETH and deposited in the Ministry of Finance.

IVD will also deploy ETH to staking, restaking and on-chain derivatives to increase returns and fluidity while adding downside protection. The move places IVD along with a small group of companies registered with HKEX, which has the Crypto Ministry of Finance.

.

Boyaa Interactive (0434.hk) After converting almost all of the ether into Bitcoin, it holds value over USD 3,100. daughter (1357.hk) I bought about 31,000 ETH and 940 BTC in 2021 Before you finish those positions.

Other small bitcoin holders include Yuxing Infotech (8005.hk) 78 at BTC, Moon Inc. (1723.hk) 18.88 BTC, and Walnut capital (0905.hk) 10 BTC from shareholder donations.

The IVD move came as part of announcing a broader partnership with Hashkey Group, which operates the hashkey exchange in Hong Kong.

Read more: Sharplink raises $200 million direct products to boost ETH Holdings to $20 billion

]]>
https://earlybirdsinvest.com/hong-kongs-ivd-medical-adds-19-million-in-ether-to-its-finances/feed/ 0 52139
Medical Tech Firm Semler Scientific Gobbles Up Another $50,000,000 Worth of Bitcoin, Now Owns More Than 4,000 BTC https://earlybirdsinvest.com/medical-tech-firm-semler-scientific-gobbles-up-another-50000000-worth-of-bitcoin-now-owns-more-than-4000-btc/ https://earlybirdsinvest.com/medical-tech-firm-semler-scientific-gobbles-up-another-50000000-worth-of-bitcoin-now-owns-more-than-4000-btc/#respond Sat, 24 May 2025 17:01:49 +0000 https://earlybirdsinvest.com/medical-tech-firm-semler-scientific-gobbles-up-another-50000000-worth-of-bitcoin-now-owns-more-than-4000-btc/

The US medical tech firm Semler Scientific has added another $50 million worth of Bitcoin (BTC) to its corporate treasury.

A new filing with the U.S. Securities and Exchange Commission (SEC) indicates the firm acquired 455 Bitcoin between May 13th and May 22nd at an average purchase price of $109,801 per BTC, including fees and expenses.

Semler now holds 4,264 Bitcoin, which it acquired for an aggregate price of $390 million at an average purchase price of $91,471 per BTC.

With BTC trading at $107,322 at time of writing, the medical tech’s holdings are currently worth more than $457.6 million.  The top-ranked crypto asset by market cap is down nearly 4% in the past 24 hours after hitting a new all-time high of $111,814 on Thursday.

Eric Semler, the founder and chairman of the firm’s board of directors, notes his company has generated a BTC yield of 25.8% year-to-date.

Data from BitcoinTreasuries.net indicates that Semler Scientific is now the 13th-ranked company in the world in terms of BTC holdings.

In May 2024, the firm became the second publicly traded company in the US to adopt a Bitcoin treasury policy, following Strategy (formerly known as MicroStrategy). Strategy, which first started investing in the asset back in 2020, has the largest corporate Bitcoin treasury in the world and currently holds 576,230 BTC worth $62.14 billion.

Follow us on X, Facebook and Telegram

Don’t Miss a Beat – Subscribe to get email alerts delivered directly to your inbox

Check Price Action

Surf The Daily Hodl Mix

&nbsp

Disclaimer: Opinions expressed at The Daily Hodl are not investment advice. Investors should do their due diligence before making any high-risk investments in Bitcoin, cryptocurrency or digital assets. Please be advised that your transfers and trades are at your own risk, and any losses you may incur are your responsibility. The Daily Hodl does not recommend the buying or selling of any cryptocurrencies or digital assets, nor is The Daily Hodl an investment advisor. Please note that The Daily Hodl participates in affiliate marketing.

Generated Image: Midjourney

]]>
https://earlybirdsinvest.com/medical-tech-firm-semler-scientific-gobbles-up-another-50000000-worth-of-bitcoin-now-owns-more-than-4000-btc/feed/ 0 38075
Basel Medical Group to add $1B in Bitcoin to treasury amid falling share prices https://earlybirdsinvest.com/basel-medical-group-to-add-1b-in-bitcoin-to-treasury-amid-falling-share-prices/ https://earlybirdsinvest.com/basel-medical-group-to-add-1b-in-bitcoin-to-treasury-amid-falling-share-prices/#respond Sat, 17 May 2025 10:09:38 +0000 https://earlybirdsinvest.com/basel-medical-group-to-add-1b-in-bitcoin-to-treasury-amid-falling-share-prices/

Singapore-based Basel Medical Group (BMGL) announced plans to acquire $1 billion worth of Bitcoin (BTC) to strengthen its balance sheet and accelerate expansion across Asian markets.

Basel also revealed that the proposed transaction is being negotiated with a consortium of institutional investors and high-net-worth individuals active in the crypto sector. 

Basel CEO Darren Chhoa said the $1 billion acquisition would give the firm “unprecedented capacity” to execute its Asia growth strategy.

He added that capital infusion would create one of the strongest balance sheets among Asia-focused medical providers, enabling it to pursue mergers and acquisitions and enhance its financial resilience.

The firm described the initiative as a “landmark transaction” that would represent one of the largest Bitcoin allocations by a healthcare group in the Asia-Pacific region.

The announcement highlighted an intention to finalize the deal within the current quarter, subject to regulatory approval and standard closing conditions. 

Transaction structure and strategic objectives

The proposed acquisition will occur through a share-swap arrangement with external investors, rather than a direct cash purchase of Bitcoin from reserves. Basel stated that this model offers enhanced capital efficiency while preserving liquidity for healthcare operations.

The company’s management sees the diversification into Bitcoin as a hedge against currency volatility and inflation risks in emerging markets, particularly in regions where it seeks to expand. 

BMGL also sees the acquisition as a mechanism to attract strategic partnerships in the healthcare and digital asset sectors.

Basel’s leadership said it would provide additional details upon the transaction’s completion and remain committed to regulatory compliance in all jurisdictions where it operates.

Market reaction diverges from Bitcoin trend

Despite Basel’s framing of the move as a financial strengthening initiative, the company’s stock price declined sharply following the announcement.

Its shares fell to a low of $2.10 despite climbing 68% earlier in the day to a high of $3.41 from the daily opening price of $2.84. The volatility adds to the massive 57% drawdown observed on May 14.

Despite the tumultuous price action for the day, the share price mounted a recovery before the trading day ended to close the day down 9.89% to $2.37 as of press time.

The reaction contrasts with recent market behavior in other firms announcing Bitcoin strategies. 

On March 12, Rumble saw its stock price rise 5% after announcing a Bitcoin acquisition. Japanese firm Metaplanet gained nearly 20% in a single session on July 22 after disclosing a purchase of more than 20 BTC

HK Asia Holdings surged 92.98% on Feb. 13 after acquiring 1 BTC for approximately $96,150. Meanwhile, Brazilian fintech Méliuz gained 16.3% on March 6 after detailing its Bitcoin investment framework,

While Basel’s initial market response diverged from those precedents, the company maintains that the transaction is part of a broader financial restructuring initiative rather than a speculative bet.

Mentioned in this article
]]>
https://earlybirdsinvest.com/basel-medical-group-to-add-1b-in-bitcoin-to-treasury-amid-falling-share-prices/feed/ 0 36719
Medical Tech Firm Semler Scientific Accumulates Another $10,000,000 Worth of Bitcoin, Now Holds 3,303 BTC https://earlybirdsinvest.com/medical-tech-firm-semler-scientific-accumulates-another-10000000-worth-of-bitcoin-now-holds-3303-btc/ https://earlybirdsinvest.com/medical-tech-firm-semler-scientific-accumulates-another-10000000-worth-of-bitcoin-now-holds-3303-btc/#respond Sat, 26 Apr 2025 23:55:50 +0000 https://earlybirdsinvest.com/medical-tech-firm-semler-scientific-accumulates-another-10000000-worth-of-bitcoin-now-holds-3303-btc/

The US medical tech firm Semler Scientific is accumulating another round of Bitcoin (BTC) worth tens of millions of dollars, bringing its total to just over 3,300 BTC.

In a new thread on the social media platform X, Eric Semler, founder and chairman of the board of directors, says that Semler Scientific has acquired 111 more BTC worth $10 million, adding that the company “is just getting started.”

In a recent press release, Semler Scientific, which adopted the top crypto asset by market cap as its primary reserve asset in May 2024, discloses that its average cost of its BTC trove is just under $88,000 per token.

“Semler Scientific acquired 111 Bitcoin for $10.0 million with an average purchase price of $90,124 per Bitcoin… As of April 24, 2025, Semler Scientific held 3,303 Bitcoin, which were acquired for an aggregate $290.4 million at an average purchase price of $87,929 per Bitcoin.”

According to the firm’s data, it has generated a BTC yield – or the metric used by the firm to keep track of the success of its Bitcoin buying strategy – of 23.5% year-to-date.

In December, the California-based company purchased 303 Bitcoin, at the time bringing its stash to 1,873 BTC purchased for $147.1 million at $78,553 per token.

Data from Bitcoin Treasuries indicates that Semler Scientific is now the 14th-ranked company in terms of BTC holdings.

The flagship digital asset is trading for $95,068 at time of writing, a 1.8% increase during the last 24 hours.

Follow us on X, Facebook and Telegram

Don’t Miss a Beat – Subscribe to get email alerts delivered directly to your inbox

Check Price Action

Surf The Daily Hodl Mix

&nbsp

Disclaimer: Opinions expressed at The Daily Hodl are not investment advice. Investors should do their due diligence before making any high-risk investments in Bitcoin, cryptocurrency or digital assets. Please be advised that your transfers and trades are at your own risk, and any losses you may incur are your responsibility. The Daily Hodl does not recommend the buying or selling of any cryptocurrencies or digital assets, nor is The Daily Hodl an investment advisor. Please note that The Daily Hodl participates in affiliate marketing.

Generated Image: Midjourney

]]>
https://earlybirdsinvest.com/medical-tech-firm-semler-scientific-accumulates-another-10000000-worth-of-bitcoin-now-holds-3303-btc/feed/ 0 32990
494,000 Americans at Risk of Bank Fraud and Identity Theft As Massive Data Breach Exposes Names, Financial Records, Medical Data, Social Security Numbers and More: Report https://earlybirdsinvest.com/494000-americans-at-risk-of-bank-fraud-and-identity-theft-as-massive-data-breach-exposes-names-financial-records-medical-data-social-security-numbers-and-more-report/ https://earlybirdsinvest.com/494000-americans-at-risk-of-bank-fraud-and-identity-theft-as-massive-data-breach-exposes-names-financial-records-medical-data-social-security-numbers-and-more-report/#respond Sat, 29 Mar 2025 02:43:13 +0000 https://earlybirdsinvest.com/494000-americans-at-risk-of-bank-fraud-and-identity-theft-as-massive-data-breach-exposes-names-financial-records-medical-data-social-security-numbers-and-more-report/

A cybersecurity incident has reportedly exposed the personal, financial and health records of nearly half a million Americans.

The mobility and assistive solutions provider Numotion says 494,000 customers are affected by a data breach witnessed between September 2nd, 2024, and November 18th, 2024, reports Security Week.

Numotion says an unknown entity managed to access the email accounts of the firm’s employees without authorization several times.

The firm says that after an extensive review, it determined that the emails in question contain sensitive customer information.

“The type of information that may have been viewed varied for each individual, but could have included names, dates of birth, product information, payment and financial account information, health insurance information, medical information, and for a minority of individuals, Social security numbers and driver’s license numbers.”

Numotion says it’s sending letters to all impacted customers to shed light on the data breach while offering identity theft protection services for users whose Social Security numbers were stolen

The firm says that for now, it hasn’t learned of any incident where a customer’s sensitive data has been misused for fraud or identity theft. But Numotion says affected customers should stay vigilant and report any strange activity related to identity theft, healthcare fraud or financial fraud.

“If individuals detect any suspicious activity, they should notify the entity with which the account is maintained, and promptly report any fraudulent activity to proper law enforcement authorities, including the police and their state attorney general.”

Numotion focuses on serving people with disabilities by providing customized assistive equipment such as wheelchairs, seating and positioning gear, as well as home accessibility and medical supplies.

Follow us on X, Facebook and Telegram

Don’t Miss a Beat – Subscribe to get email alerts delivered directly to your inbox

Check Price Action

Surf The Daily Hodl Mix

&nbsp

Disclaimer: Opinions expressed at The Daily Hodl are not investment advice. Investors should do their due diligence before making any high-risk investments in Bitcoin, cryptocurrency or digital assets. Please be advised that your transfers and trades are at your own risk, and any losses you may incur are your responsibility. The Daily Hodl does not recommend the buying or selling of any cryptocurrencies or digital assets, nor is The Daily Hodl an investment advisor. Please note that The Daily Hodl participates in affiliate marketing.

Generated Image: Midjourney

]]>
https://earlybirdsinvest.com/494000-americans-at-risk-of-bank-fraud-and-identity-theft-as-massive-data-breach-exposes-names-financial-records-medical-data-social-security-numbers-and-more-report/feed/ 0 27787
We’re entering the medical era of wearables https://earlybirdsinvest.com/were-entering-the-medical-era-of-wearables/ https://earlybirdsinvest.com/were-entering-the-medical-era-of-wearables/#respond Sun, 16 Feb 2025 19:02:23 +0000 https://earlybirdsinvest.com/were-entering-the-medical-era-of-wearables/

Smartwatches and smart rings are “wellness” devices. They may have some FDA-approved sensors, but there’s always fine print saying to take worrying readings with a grain of salt. But smartwatch and smart ring makers are aiming for medical-grade accuracy at all costs (literally). Not necessarily for your peace of mind, but because there’s profit to be had if the healthcare industry buys in.

Sunday Runday

Lloyd, the Android Central mascot, break-dancing

(Image credit: Android Central)

In this weekly column, Android Central Wearables Editor Michael Hicks talks about the world of wearables, apps, and fitness tech related to running and health, in his quest to get faster and more fit.

The OnePlus Watch 3 dominated headlines last week because of its 5-day battery, so you probably missed the news about OnePlus opening a €13.5 million 4,840m² Health Lab in Guangdong, China. Run by “medical professionals and multidisciplinary software and hardware engineers,” it’s designed for “long-term research collaborations” with over 30 medical companies and research institutions to study athletes’ physiological data.

As a side benefit, OnePlus will use lab sensors to “improve the ability of self-developed algorithms, allowing smartwatches to better monitor exercise capacity and cardiopulmonary health.”

That may all sound a bit intense, but it’s no surprise. Dive into the career pages for Apple and Google, and you’ll find open jobs related to clinical studies, health sensor development, data center construction, health privacy, biophotonics — the list truly goes on and on. Cardiologists and smartwatch engineers have intertwined career paths in Big Tech.

Some of this research goes into new health data points; Apple is reportedly closing in on blood pressure tracking, while a Samsung exec hinted last month that non-invasive blood glucose monitoring is coming soon. Pulling that off takes serious R&D.

Other research focuses on better HR algorithms for athletes, like Google claiming the Pixel Watch 3 has the “most accurate heart rate for running yet” to try and pull customers away from fitness brands like Garmin and Polar. This watch was also the first with a “Loss of Pulse” feature.

But to be frank, courting athletes or consumers with health issues won’t justify this investment. Google didn’t buy Fitbit for $2.1 billion just to make its future Pixel Watches more accurate, and OnePlus’s new sports lab isn’t really about the casual athletes that wear its watches.

I believe a business-to-business (B2B) battle is coming for smartwatches (and smart rings) that are all trying to be the clinical, portable option for other industries. They’re all racing to collect your data and use it to self-improve their results until they can aim their sights higher. And you getting heart health warnings or daily workout recommendations is only a side effect.

Big Tech x Healthcare = profit?

Apple Watch Series 9 long-term review

(Image credit: Apoorva Bhardwaj / Android Central)

The other smartwatch health news that prompted this column was Apple announcing its latest Health Study on how to use technology to “predict, detect, monitor, and manage changes in participants’ health,” across “a number of health and disease areas, including activity, aging, cardiovascular health, circulatory health, cognition, hearing, menstrual health, mental health, metabolic health, mobility, neurologic health, respiratory health, sleep, and more.”

This ambitious, holistic study isn’t being handled in a creepy way: It’s an opt-in program with options on what you share with researchers, and Apple itself doesn’t get identifying information.

What it will get is the overall results, from potentially millions of customers, showing which data its watches successfully track and which areas it fails at, adding context that it can’t normally find out on its own.

That kind of data can be incredibly valuable for preventative care, if it can analyze your health and workout trends and warn you of potential changes to your physiology or mental capacity. That could help you, but it’ll certainly help Apple keep you in its device ecosystem if it keeps marketing its Watches as life-saving.

Apple Watch | Dear Apple | Apple – YouTube
Apple Watch | Dear Apple | Apple - YouTube


Watch On

Everyone is intrigued by blood pressure and glucose, but we’re seeing right now how smartwatches are analyzing your AGEs Index, arterial stiffness, and other niche bodily health information that’s tied to long-term health warning signs. I don’t think any consumers were asking for this; I think it’s a proof of concept for doctors to prove how useful these devices can be if they join forces.

Imagine if Apple partnered with your healthcare provider and could key in its watches to look out for specific biomarkers related to your condition or genetics. Some smartwatches can already collect data to send to your doctor, but perhaps these apps could automatically send reports, either at regular intervals or whenever there’s a sustained issue with a given metric.

‘Wellness’ is becoming old news

A press photo of the rose gold Circular Ring 2 sitting on a rose petal

(Image credit: Circular)

Smart ring sales are so niche that they’re barely worth mentioning compared to smartwatches. But I think it’s relevant that so many smart ring brands at CES pushed their medical-grade accuracy and brought up unprompted the idea of B2B sales to medical companies.

The Circular Ring 2 ditched the company’s trademark haptic engine for an FDA-approved ECG; in the CEO’s words, they’re transitioning from wellness to an alternative for “expensive” and “invasive” medical checks. The Evie Ring got FDA approval for blood oxygen readings, and its CEO also labeled it as a “clinical-grade device for B2B channels.” Ultrahuman wants you to send them blood so they can compare your smart ring data against your biomarkers, and Oura has its new Symptom Radar to link your biometrics with possible causes.

These new companies want to leapfrog wellness straight into the health industry for a reason. Either they think it’s a market ready to be tapped, or they think “wellness” alone will be seen as less marketable or profitable very soon. Whether smart rings are successful against Big Tech brands with more resources to throw into this gambit, they’re shooting their shot.

Is this a good or a bad trend? Yes.

There’s nothing inherently wrong with Apple Watches, Android smartwatches, or smart rings becoming so accurate that they can be relied upon for clinical trials. You can be skeptical that they’re as accurate as these companies want them to be, but I won’t censure them for striving for something potentially unattainable instead of coasting on “wellness” estimates.

What I worry about — and I’ve written about this before — is that it’s genuinely tough to be confronted by bad smartwatch readings on a daily basis.

Anyone would want their watch to catch signs of a heart attack so you can call your doctor. But if they start tracking your body’s poor health markers that signal potential issues years or decades down the line, will that help you turn your life around, or just send you spiraling into stress and fatalism?

Sleep Apnea warning on Apple Watch Series 10 and iPhone 16

(Image credit: Apple)

I know someone who spotted a potential kidney issue because their smart scale told them they were constantly dehydrated no matter how much water they drank. This was vital information to know, but in the aftermath, the smart scale app continued to warn them. They started checking this data more often, hoping lifestyle changes would immediately fix the problem; when nothing helped, they felt hopeless.

Of course I want to know if I have arterial stiffness or high blood sugar, but once I do know, I’ll continue to be confronted by this information. Smartwatches have all these gamefied tools like daily rings meant to encourage you to become healthier, but some health issues can’t be solved by a gung-ho attitude.


I won’t be surprised if, within the next five to ten years, we start seeing more doctors prescribing smartwatches and smart rings for at-home monitoring as an affordable alternative to expensive equipment, with these brands offering a spinoff healthcare app that highlights specific information shared with you and your doctor.

The current AI revolution will play into this, of course. Medical journals are already being fed into specialized AIs; the next step is for your actual health data and testing results to power future insights. Apple’s research study and OnePlus’s specialized lab will only become increasingly common, feeding AI data that (again) these companies can sell to healthcare providers.

The side effect of this is simple: You’re going to get bombarded with more and more health and wellness information the moment you put on your smartwatch. And some people will be overwhelmed by it.

You can mentally prepare yourself for bad news before visiting a doctor; it’s harder to do the moment you wake up and see a health warning in your smartwatch’s Morning Report.

]]>
https://earlybirdsinvest.com/were-entering-the-medical-era-of-wearables/feed/ 0 19903